• 1ST AUGUST 2023

    Book now for our Price Concessions Webinar

    Community Pharmacy England will be hosting a webinar on price concessions to help to explain how the concessions system works and what happens when pharmacy owners report increased prices to us, and to answer your questions and hear further feedback for the Department of Health and Social Care (DHSC). While the concessions system is designed

    Read more
    • 1ST AUGUST 2023

    July Price Concessions Update

    Following several weeks of discussion during which Community Pharmacy England made strong representations and put weekly evidence from pharmacy owners to the Department of Health and Social Care (DHSC), late on Monday (July 31st) DHSC announced its final price concessions for July. Several of the prices announced represented improvements on the original DHSC offers following

    Read more
    • 31ST JULY 2023

    July 2023 Price Concessions Final Update

    Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (31/07/2023) announced the following final list of price concessions for July 2023: Drug Pack size Price concession Aciclovir 200mg tablets 25 £1.76 Atorvastatin 20mg tablets 28 £3.38 Atorvastatin

    Read more
    • 31ST JULY 2023

    Medicine Supply Notification: Tegretol® (carbamazepine) 100mg tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Tegretol® (carbamazepine) 100mg tablets. MSN/2023/074 Tier 2 – medium impact Date of issue 31st July 2023 Tegretol® (carbamazepine) 100mg tablets will be out of stock during August 2023 Tegretol® 200mg tablets and Tegretol® 100mg/5ml liquid remain available and will be able

    Read more
    • 31ST JULY 2023

    Medicine Supply Notification: Reboxetine (Edronax®) 4mg tablets

    Department of Health and Social Care (DHSC) has issued a medicine supply notification for Reboxetine (Edronax®) 4mg tablets. MSN/2023/073 Tier 2 – medium impact Date of issue 31st July 2023 Reboxetine (Edronax®) 4mg tablets are out of stock from mid-August until the end of October 2023. Unlicensed imported stock is available (see details below) If

    Read more